Moderna vaccine trial aimed at Ebola outbreak begins in Nova Scotia
Moderna has launched a clinical trial in Canada for an experimental mRNA vaccine targeting the Bundibugyo ebolavirus. The study is supported by the Coalition for Epidemic Preparedness Innovations and aims to address a current outbreak.
Why it matters
Developing vaccines for rare or emerging viral threats is essential for global health security and demonstrates the versatility of mRNA technology.
Copy Link Email X Reddit Pinterest LinkedIn Tumblr Moderna vaccine trial aimed at international Ebola outbreak begins in Nova Scotia Research sites in Truro, Halifax working with Moderna on a vaccine for the virus at the core of a current outbreak
The first participant getting dosed in Moderna's clinical trial for a new vaccine against Bundibugyo ebolavirus in Truro. Photo by Kelly Clark Photography / Moderna Article content The first participants in Moderna’s new trial for an experimental vaccine got their dose in Truro this week, and a similar trial in Halifax will follow suit in the coming days.
Create an account or sign in to continue your reading experience.
This launches the company’s efforts against the current Ebola outbreak.
They are testing mRNA-1469, an experimental vaccine currently under study to prevent Bundibugyo virus disease (BVD), caused by Bundibugyo ebolavirus (BDBV).
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in